Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2003
04/08/2003US6545126 Chimeric toxins
04/08/2003US6545124 Antiproliferative agents
04/08/2003US6545123 Synthesis without the use of the cells and their use in vivo as powerful anti-inflammatory, antithrombotic or anti-metastatic compounds
04/08/2003US6544959 High affinity nucleic acid ligands to lectins
04/08/2003US6544956 Selectively killing a human neoplastic cell by administering a nucleic acid encoding and expressing a peptide comprising at least 8 to 18 contiguous acidic amino acids that are aspartic and glutamic acid
04/08/2003US6544955 Method of sensitizing tumor cells with adenovirus E1A
04/08/2003US6544949 Analogs of parathyroid hormone
04/08/2003US6544948 ΔP62, variants thereof, amino acid sequences coding therefor and their uses in gene therapy for cancer
04/08/2003US6544786 Method and vector for producing and transferring trans-spliced peptides
04/08/2003US6544785 Helper viruses; genetic engineering
04/08/2003US6544784 Multiple-tumor aberrant growth genes
04/08/2003US6544780 Adenovirus vector with multiple expression cassettes
04/08/2003US6544772 Genetic engineering; isolated from Lctobacillus
04/08/2003US6544771 Retroviral gene therapy vectors and therapeutic methods based thereon
04/08/2003US6544761 Nucleotide sequences coding polypeptide for use in treatment of restenosis, arthritis and cancer
04/08/2003US6544760 Kunitz domain polypeptide Zkun11
04/08/2003US6544759 Polynucleotides encoding a novel growth factor which acts through ErbB-4 kinase receptor tyrosine
04/08/2003US6544758 Methods for expressing endostatin protein
04/08/2003US6544757 Genetic engineering; hepatitis virus
04/08/2003US6544753 Dietetics; analgesics; cognition activators; detecting binding
04/08/2003US6544752 Anigenically-marked non-infectious retrovirus-like particles
04/08/2003US6544750 Prevent thrombosis
04/08/2003US6544748 Preparation of erythropoietin by endogenous gene activation
04/08/2003US6544745 Monitoring, detecting, screening and determining pancreatic defects in humans; obtain and determine nucleotide sequence of sample, compare to control, detect mutation, evaluate human for pancreatic defects
04/08/2003US6544743 Peroxisome proliferator-activated receptor alpha and disorders of lipid metabolism
04/08/2003US6544735 Determination gene expression; calibration
04/08/2003US6544733 Method of identifying non-host plant disease resistance genes
04/08/2003US6544731 Genetic engineering; binding antibodies
04/08/2003US6544728 Methods and kits for diagnosing human immunodeficiency virus type 2 (HIV-2), proteins of HIV-2, and vaccinating agents for HIV-2
04/08/2003US6544544 Compound which disrupts microtubule function and polymeric carrier, with proviso that polymeric carrier is not a capsule
04/08/2003US6544527 Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region
04/08/2003US6544526 For immunization of horses
04/08/2003US6544523 Mutant forms of Fas ligand and uses thereof
04/08/2003US6544522 Fusion proteins of mycobacterium tuberculosis antigens and their uses
04/08/2003US6544521 Immunoreactive peptide CTL epitopes of human cytomegalovirus pp150
04/08/2003US6544520 Isolated, purified peptide that inhibits hepatitis B virus assembly by binding to the core antigen of hepatitis B virus and preventing association
04/08/2003US6544519 Polypeptide originating in haemophilus paragallinarum and process for producing the same
04/08/2003US6544517 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
04/08/2003US6544516 Treating with anitbodies for bactericidal activity against enterococci
04/08/2003US6544512 Suppression of powdery mildew on plants; fungicides
04/08/2003US6544507 Anti-neoplastic viral agents
04/08/2003US6544505 Interferon-epsilon
04/08/2003CA2205015C Method for producing biologicals in protein-free culture
04/08/2003CA2191344C Synthetic peptide analogs of lung surfactant protein sp-c
04/08/2003CA2184584C Vascular endothelial growth factor 2
04/08/2003CA2172245C Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein
04/08/2003CA2160603C Sequence of the hyaluronan receptor gene
04/08/2003CA2127470C Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis
04/08/2003CA2109830C Lhrh antagonists and intermediate products
04/08/2003CA2109193C Gaba-a receptor subunits (.alpha.-2,.alpha.-3,.alpha.-5,.alpha.-6,.beta.-2) and transfected cells expressing them
04/08/2003CA2107732C Retrovirus from the hiv group and its use
04/08/2003CA2103829C Peg-interferon conjugates
04/08/2003CA2050300C Tnf-inhibiting proteins and the preparation thereof
04/08/2003CA2008368C Soluble molecule related to but distinct from icam-1
04/08/2003CA2006332C Method of detecting neurological disease or dysfunction
04/04/2003WO2002029063A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same
04/04/2003CA2424877A1 Novel recombinant feline herpesvirus 1 and polyvalent vaccine with the use of the same
04/03/2003WO2003028001A2 Method and pharmaceutical composition for inducing cancer cell-specific apoptosis by combination with tnf family proteins and flavopiridol
04/03/2003WO2003027991A1 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
04/03/2003WO2003027672A1 Novel screening method using prokineticin receptor
04/03/2003WO2003027639A2 Glucocorticoid receptor nuclear translocation domain
04/03/2003WO2003027637A2 Assessment of neurons in the arcuate nucleus to screen for agents that modify feeding behavior
04/03/2003WO2003027322A2 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas
04/03/2003WO2003027321A2 Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
04/03/2003WO2003027320A2 Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
04/03/2003WO2003027312A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/03/2003WO2003027296A1 GENES PARTICIPATING IN THE SYNTHESIS OF FATTY ACID HAVING trans-11-, cis-13- CONDJUGATED DOUBLE BOND AND UTILIZATION THEREOF
04/03/2003WO2003027295A2 Methods for diagnosis and treatment of diseases associated with altered expression of jak1
04/03/2003WO2003027291A2 Hdv nucleic acid molecules, fragments and applications thereof
04/03/2003WO2003027290A1 Method of imparting or controlling fertility with the use of fertility restoring gene for rice bt-male sterility cytoplasm and method of judging the existence of fertility restoring gene
04/03/2003WO2003027289A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003WO2003027288A1 Diagnostic method for cancer characterized in the detection of the deletion of g-csf exon 3
04/03/2003WO2003027287A1 Kidney-specific urate transporter and gene thereof
04/03/2003WO2003027286A1 Method of synthesizing polynucleotide via reverse translation from protein and oligonucleotide to be used in this method
04/03/2003WO2003027285A1 Dna sequences for human angiogenesis genes
04/03/2003WO2003027282A1 Adamts-15, -16, -17, -18 and -19
04/03/2003WO2003027279A1 p300 HISTONE ACETYLASE INHIBITOR
04/03/2003WO2003027276A2 Novel compositions and methods for diagnosis and treatment of lymphoma and leukemia
04/03/2003WO2003027274A2 Purified polypeptides from pseudomonas aeruginosa
04/03/2003WO2003027269A1 Chronic pathogen-expressing cell lines
04/03/2003WO2003027266A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/03/2003WO2003027263A2 Proteins associated with cell growth, differentiation, and death
04/03/2003WO2003027255A2 Anti-fusion assay
04/03/2003WO2003027254A2 15625 receptor, a novel g-protein coupled receptor
04/03/2003WO2003027253A2 Variants of alpha-fetoprotein coding and expression sequences
04/03/2003WO2003027252A2 Isolated dna molecules encoding humanized calcitonin gene-related peptide receptor, related non-human transgenic animals and assay methods
04/03/2003WO2003027251A2 Novel molecules of the pyrin domain protein family and uses thereof
04/03/2003WO2003027249A2 High-protein-phenotype-associated plant genes
04/03/2003WO2003027248A2 Antibody inhibitors of gdf-8 and uses thereof
04/03/2003WO2003027246A2 Antagonists
04/03/2003WO2003027242A2 Fas ligand
04/03/2003WO2003027240A2 Rhesus monkey, dog and ferret melanin-concentrating hormone type 1 receptor
04/03/2003WO2003027239A2 Melanin-concentrating hormone receptor antagonist binding protein
04/03/2003WO2003027235A2 Afap sequences, polypeptides, antibodies and methods
04/03/2003WO2003027231A2 Polynucleotide encoding adapter protein, pmn29
04/03/2003WO2003027230A2 Cell adhesion and extracellular matrix proteins
04/03/2003WO2003027228A2 Receptors and membrane-associated proteins
04/03/2003WO2003027151A1 Recombinant anti-osteopontin antibody and use thereof
04/03/2003WO2003027148A1 Disulfide-reduced neogalactosyl serum albumin and use of radiolabeled derivative thereof for liver imaging
04/03/2003WO2003027147A2 Human coagulation factor vii polypeptides
1 ... 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 ... 2916